Literature DB >> 28990911

Plasmodium Species Infecting Children Presenting with Malaria in Uganda.

Victor Asua1, Stephen Tukwasibwe1, Melissa Conrad2, Andrew Walakira1, Joaniter I Nankabirwa3,1, Levicatus Mugenyi1, Moses R Kamya3,1, Samuel L Nsobya3,1, Philip J Rosenthal2.   

Abstract

Contributions of species other than Plasmodium falciparum to human malaria in sub-Saharan Africa are uncertain. We collected blood from children aged 6 months to 10 years diagnosed with malaria by Giemsa-stained blood smears (176 subjects) or histidine rich protein-2-based rapid diagnostic tests (323 subjects) in 2016; 50 samples from each of 10 sites across Uganda were studied to identify infecting species. Of 499 available samples, 474 demonstrated plasmodial infection by polymerase chain reaction amplification of 18S ribosomal RNA genes, including P. falciparum in 472, Plasmodium malariae in 22, Plasmodium ovale in 15, and Plasmodium vivax in four; 435 were pure P. falciparum, two did not contain P. falciparum, and the remainder were mixed infections including P. falciparum. The prevalence of nonfalciparum species varied geographically. Stratifying based on recent history of indoor residual spraying (IRS) of insecticides, nonfalciparum infections were seen in 27/189 (14.8%) samples from sites that received and 13/285 (4.6%) samples from sites that did not receive IRS since 2010 (P = 0.0013). Overall, 39/474 (8.2%) samples from individuals diagnosed with malaria included nonfalciparum infections. Thus, a substantial proportion of episodes of malaria in Uganda include infections with plasmodial species other than P. falciparum.

Entities:  

Mesh:

Year:  2017        PMID: 28990911      PMCID: PMC5590612          DOI: 10.4269/ajtmh.17-0345

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  26 in total

1.  Level and dynamics of malaria transmission and morbidity in an equatorial area of South Cameroon.

Authors:  S Bonnet; R E l Paul; C Gouagna; I Safeukui; J-Y Meunier; R Gounoue; C Boudin
Journal:  Trop Med Int Health       Date:  2002-03       Impact factor: 2.622

2.  Are artemisinin-based combination therapies effective against Plasmodium malariae?

Authors:  Guido Calleri; Rosanna Balbiano; Pietro Caramello
Journal:  J Antimicrob Chemother       Date:  2013-01-22       Impact factor: 5.790

3.  Plasmodium falciparum and P. malariae epidemiology in a West African village.

Authors:  C Boudin; V Robert; J P Verhave; P Carnevale; P Ambroise-Thomas
Journal:  Bull World Health Organ       Date:  1991       Impact factor: 9.408

4.  The epidemiology of malaria in southern Sierra Leone.

Authors:  G Barnish; G H Maude; M J Bockarie; T A Eggelte; B M Greenwood
Journal:  Parassitologia       Date:  1993-07

5.  Identification of the four human malaria parasite species in field samples by the polymerase chain reaction and detection of a high prevalence of mixed infections.

Authors:  G Snounou; S Viriyakosol; W Jarra; S Thaithong; K N Brown
Journal:  Mol Biochem Parasitol       Date:  1993-04       Impact factor: 1.759

6.  Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa.

Authors:  C V Plowe; A Djimde; M Bouare; O Doumbo; T E Wellems
Journal:  Am J Trop Med Hyg       Date:  1995-06       Impact factor: 2.345

7.  The Dielmo project: a longitudinal study of natural malaria infection and the mechanisms of protective immunity in a community living in a holoendemic area of Senegal.

Authors:  J F Trape; C Rogier; L Konate; N Diagne; H Bouganali; B Canque; F Legros; A Badji; G Ndiaye; P Ndiaye
Journal:  Am J Trop Med Hyg       Date:  1994-08       Impact factor: 2.345

8.  Incidence of malaria and efficacy of combination antimalarial therapies over 4 years in an urban cohort of Ugandan children.

Authors:  Tamara D Clark; Denise Njama-Meya; Bridget Nzarubara; Catherine Maiteki-Sebuguzi; Bryan Greenhouse; Sarah G Staedke; Moses R Kamya; Grant Dorsey; Philip J Rosenthal
Journal:  PLoS One       Date:  2010-07-30       Impact factor: 3.240

9.  Seroepidemiology of Plasmodium species infections in Zimbabwean population.

Authors:  Seth A Amanfo; Takafira Mduluza; Nicholas Midzi; David R Cavanagh; Francisca Mutapi
Journal:  Malar J       Date:  2016-05-10       Impact factor: 2.979

10.  Detection of persistent Plasmodium spp. infections in Ugandan children after artemether-lumefantrine treatment.

Authors:  Martha Betson; José C Sousa-Figueiredo; Aaron Atuhaire; Moses Arinaitwe; Moses Adriko; Gerald Mwesigwa; Juma Nabonge; Narcis B Kabatereine; Colin J Sutherland; J Russell Stothard
Journal:  Parasitology       Date:  2014-05-16       Impact factor: 3.234

View more
  13 in total

Review 1.  Plasmodium vivax Infections of Duffy-Negative Erythrocytes: Historically Undetected or a Recent Adaptation?

Authors:  Karthigayan Gunalan; Amadou Niangaly; Mahamadou A Thera; Ogobara K Doumbo; Louis H Miller
Journal:  Trends Parasitol       Date:  2018-03-09

2.  Prevalence of arps10, fd, pfmdr-2, pfcrt and pfkelch13 gene mutations in Plasmodium falciparum parasite population in Uganda.

Authors:  Moses Ocan; Fred Katabazi Ashaba; Savannah Mwesigwa; Kigozi Edgar; Moses R Kamya; Sam L Nsobya
Journal:  PLoS One       Date:  2022-05-05       Impact factor: 3.752

3.  Comparison of Capillary Versus Venous Blood for the Diagnosis of Plasmodium falciparum Malaria Using Rapid Diagnostic Tests.

Authors:  Abalinda M Gorret; Rabbison Muhindo; Emma Baguma; Moses Ntaro; Edgar M Mulogo; Molly Deutsch-Feldman; Jonathan J Juliano; Dan Nyehangane; Ross M Boyce
Journal:  J Infect Dis       Date:  2021-07-02       Impact factor: 5.226

4.  Prevalence and proportion of Plasmodium spp. triple mixed infections compared with double mixed infections: a systematic review and meta-analysis.

Authors:  Manas Kotepui; Kwuntida Uthaisar Kotepui; Giovanni D Milanez; Frederick R Masangkay
Journal:  Malar J       Date:  2020-06-24       Impact factor: 2.979

5.  Malaria patterns across altitudinal zones of Mount Elgon following intensified control and prevention programs in Uganda.

Authors:  Aggrey Siya; Bosco John Kalule; Benard Ssentongo; Akim Tafadzwa Lukwa; Anthony Egeru
Journal:  BMC Infect Dis       Date:  2020-06-17       Impact factor: 3.090

Review 6.  Exploring Antimalarial Herbal Plants across Communities in Uganda Based on Electronic Data.

Authors:  Denis Okello; Youngmin Kang
Journal:  Evid Based Complement Alternat Med       Date:  2019-09-15       Impact factor: 2.629

7.  Comparison of Plasmodium ovale curtisi and Plasmodium ovale wallikeri infections by a meta-analysis approach.

Authors:  Aongart Mahittikorn; Frederick Ramirez Masangkay; Kwuntida Uthaisar Kotepui; Giovanni De Jesus Milanez; Manas Kotepui
Journal:  Sci Rep       Date:  2021-03-19       Impact factor: 4.379

8.  Plasmodium vivax Infection in Duffy-Negative People in Africa.

Authors:  Peter A Zimmerman
Journal:  Am J Trop Med Hyg       Date:  2017-09       Impact factor: 2.345

9.  Deletions of pfhrp2 and pfhrp3 genes were uncommon in rapid diagnostic test-negative Plasmodium falciparum isolates from Uganda.

Authors:  Sam L Nsobya; Andrew Walakira; Elizabeth Namirembe; Moses Kiggundu; Joaniter I Nankabirwa; Emmanuel Ruhamyankaka; Emmanuel Arinaitwe; Melissa D Conrad; Moses R Kamya; Grant Dorsey; Philip J Rosenthal
Journal:  Malar J       Date:  2021-01-02       Impact factor: 2.979

10.  Estimating Annual Fluctuations in Malaria Transmission Intensity and in the Use of Malaria Control Interventions in Five Sub-Saharan African Countries.

Authors:  Elisha Adeniji; Kwaku Poku Asante; Owusu Boahen; Guillaume Compaoré; Boubacar Coulibaly; Seyram Kaali; Youssouf Kabore; Mathieu Lamy; John Lusingu; Anangisye Malabeja; Petra Mens; Mattéa Orsini; Lucas Otieno; Walter Otieno; Seth Owusu-Agyei; Janet Oyieko; Jean-Yves Pirçon; Nicolas Praet; François Roman; Ali Sie; Valentine Sing'oei; Sodiomon B Sirima; Khadime Sylla; Roger Tine; Alfred B Tiono; Mathilda Tivura; Effua Usuf; Stéphanie Wéry
Journal:  Am J Trop Med Hyg       Date:  2020-11       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.